A unpublished study demonstrated that an ingredient combining prickly pear and olive leaf, called Mucosave FG, had bifidogenic activity comparable to inulin.
Bionap (Belpasso, Sicily) has announced the results of a recent in vitro study that has yet to be published. The study demonstrated that an ingredient combining prickly pear and olive leaf, called Mucosave FG, had bifidogenic activity comparable to inulin. Additional preclinical data supports the prebiotic activity of Mucosave FG because it was able to modulate the gut microbiota through direct growth stimulation of beneficial bacteria or through antimicrobial effects on bacterial pathogens. This means that the ingredient may help balance the gut microbiome in those suffering from gastrointestinal disorders.
"We're pleased to demonstrate the prebiotic activity of Mucosave FG on bifidobacteria," said Andrea Bonina, managing director for Bionap. "In addition to these preliminary data, we're also conducting a more extensive clinical study further examining its prebiotic activity and how it impact intestinal microbiota evolution."
Mucosave FG was specifically designed to for gastric mucosal support and stomach discomfort. The ingredient is supported by three clinical studies, two of which are in process to be published.